000 | 01885 a2200553 4500 | ||
---|---|---|---|
005 | 20250514055316.0 | ||
264 | 0 | _c20030312 | |
008 | 200303s 0 0 eng d | ||
022 | _a0270-9139 | ||
024 | 7 |
_a10.1053/jhep.2003.50031 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchaefer, Martin | |
245 | 0 | 0 |
_aAdherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. _h[electronic resource] |
260 |
_bHepatology (Baltimore, Md.) _cFeb 2003 |
||
300 |
_a443-51 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAlcohol Drinking |
650 | 0 | 4 |
_aAntidepressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
650 | 0 | 4 |
_aDepression _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMedical Records |
650 | 0 | 4 |
_aMental Disorders _xetiology |
650 | 0 | 4 |
_aMethadone _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPatient Compliance |
650 | 0 | 4 | _aPatient Dropouts |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRibavirin _xadverse effects |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSubstance-Related Disorders _xdrug therapy |
700 | 1 | _aSchmidt, Folkhard | |
700 | 1 | _aFolwaczny, Christian | |
700 | 1 | _aLorenz, Reinhard | |
700 | 1 | _aMartin, Gaby | |
700 | 1 | _aSchindlbeck, Norbert | |
700 | 1 | _aHeldwein, Walter | |
700 | 1 | _aSoyka, Michael | |
700 | 1 | _aGrunze, Heinz | |
700 | 1 | _aKoenig, August | |
700 | 1 | _aLoeschke, Klaus | |
773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 37 _gno. 2 _gp. 443-51 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1053/jhep.2003.50031 _zAvailable from publisher's website |
999 |
_c12342478 _d12342478 |